| pubmed-article:21327925 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0278502 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0220656 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C1704242 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C1334988 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:21327925 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21327925 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21327925 | pubmed:dateCreated | 2011-3-15 | lld:pubmed |
| pubmed-article:21327925 | pubmed:abstractText | Paclitaxel has shown promise against advanced gastric cancer and associated malignant ascites with non-measurable lesions. In order to evaluate the therapeutic effect of paclitaxel against malignant gastric ascites, a prospective phase II clinical trial was designed according to our previously proposed criteria represented by the clinical benefit response in gastric cancer (CBR-GC) criteria and the five-point method (5PM). | lld:pubmed |
| pubmed-article:21327925 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21327925 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21327925 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21327925 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21327925 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21327925 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21327925 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21327925 | pubmed:issn | 1436-3291 | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:ShiozakiHitos... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:NakamuraMasak... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:YumibaTakeyos... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:OriuchiNoboru... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:IishiHiroyasu... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:NaraharaHiroy... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:SakamotoJunic... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:MoritaSatoshi... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:MorimotoTakas... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:KakutaniChiek... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:ImamotoHaruhi... | lld:pubmed |
| pubmed-article:21327925 | pubmed:author | pubmed-author:ObaKojiK | lld:pubmed |
| pubmed-article:21327925 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21327925 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:21327925 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21327925 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21327925 | pubmed:pagination | 81-90 | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:meshHeading | pubmed-meshheading:21327925... | lld:pubmed |
| pubmed-article:21327925 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21327925 | pubmed:articleTitle | Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. | lld:pubmed |
| pubmed-article:21327925 | pubmed:affiliation | Department of Surgery, Kinki University, Osaka, Japan. | lld:pubmed |
| pubmed-article:21327925 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21327925 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21327925 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:21327925 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
